✦ LIBER ✦
Phase II Clinical Trial Design for Noncytotoxic Anticancer Agents for Which Time to Disease Progression Is the Primary Endpoint
✍ Scribed by Rosemarie Mick; John J Crowley; Raymond J Carroll
- Book ID
- 114186748
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 419 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0197-2456
No coin nor oath required. For personal study only.